A Win For VYNE Therapeutics Inc.
Wed, Jun 25, 2025 at 07:21 PM
VYNE Therapeutics Inc. (VYNE:NASDAQ) shot up at $1.37, representing a gain of 29.2%. On Wed, Jun 25, 2025, VYNE:NASDAQ touched a New 2-Week High of $1.37. From Wed, Jun 11, 2025, the stock recorded 55.56% Up Days and 40.00% Green Days
About VYNE Therapeutics Inc. (VYNE:NASDAQ)
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.
Top 10 Gainers:
- Urgent.ly Inc. (ULY:NASDAQ), 82.37%
- Vor Biopharma Inc. (VOR:NASDAQ), 74.28%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 68.45%
- XCF Global Inc. (SAFX:NASDAQ), 32.75%
- Anbio Biotechnology (NNNN:NASDAQ), 32.18%
- QuantumScape Corporation (QS:NYSE), 30.95%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 29.25%
- F45 Training Holdings Inc. (FXLV:NYSE), 27.66%
- Lianhe Sowell International Group Ltd (LHSW:NASDAQ), 26.67%
- X3 Holdings Co., Ltd. (XTKG:NASDAQ), 26.56%